APA (7th ed.) Citation

S, Z., H, Z., X, D., Z, Q., Y, M., H, C., . . . W, Z. (2026). Case Report: Early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer. Frontiers in immunology, 17, 1866469. https://doi.org/10.3389/fimmu.2026.1866469

Chicago Style (17th ed.) Citation

S, Zhang, Zhang H, Dong X, Qi Z, Ma Y, Chang H, Li Y, and Zhang W. "Case Report: Early Regression and Bladder-intact Survival After Limited-course Immunotherapy-based Systemic Therapy in Two Patients with Clinically Staged Bulky Muscle-invasive Bladder Cancer." Frontiers in Immunology 17 (2026): 1866469. https://doi.org/10.3389/fimmu.2026.1866469.

MLA (9th ed.) Citation

S, Zhang, et al. "Case Report: Early Regression and Bladder-intact Survival After Limited-course Immunotherapy-based Systemic Therapy in Two Patients with Clinically Staged Bulky Muscle-invasive Bladder Cancer." Frontiers in Immunology, vol. 17, 2026, p. 1866469, https://doi.org/10.3389/fimmu.2026.1866469.